Skip to main content Skip to main navigation menu Skip to site footer

Effect of Andrographis paniculata tablet (AS201-01) on Transforming Growth Factor Beta (TGF-β) expression and parasite inhibition in mice placenta infected with Plasmodium berghei

  • Aty Widyawaruyanti ,
  • Jatmiko Rachmat ,
  • Nurya Viandika ,
  • Hilkatul Ilmi ,
  • Lidya Tumewu ,
  • Budi Prasetyo ,

Abstract

Background: Transforming Growth Factor β (TGF-β) is a cytokine regulator of inflammation that important in inhibited parasite growth and preventing inflammation. Andrographis paniculata was empirically used as traditional medicine in Indonesia to cure malaria by activating TGF-β. Preliminary studies showed that AS201-01 tablets containing the ethyl acetate fraction of A. paniculata had been shown to inhibit the growth of Plasmodium berghei.

Aims: This study aims to determine the effect of the AS201-01 tablet on parasite inhibition and TGF-β expression in P.berghei infected mice placenta.

Methods: About 24 pregnant mice were divided into 4 groups: healthy pregnant mice (normal) (G1), untreated infected pregnant mice (negative control) (G2), infected pregnant mice treated by AS201-01 tablets (G3), and infected pregnant mice treated with Dihydroartemisinine-piperaquine (positive control) (G4). About 1x106 parasitemia were infected on the 9th day of pregnancy, while therapy was administered on the 11th day of pregnancy. The placenta was collected at the 15th day of pregnancy. The parasite inhibition and TGF-β expression were evaluated using Hematoxylin-Eosin (HE)  and immunohistochemistry assay.

Results: The results showed that the parasite still found in the placenta of G2, G3, and G4 still, but parasite of placental in G2 was higher than G3 and G4. There was a significant difference in the parasite inhibition between G2 with G3 and G4 (p<0.05). In addition, the immunohistochemistry assay found that there was a significant difference in TGF-β expression between G2 with G3, G4, and G1 (p<0.05).

Conclusion: Administration of the AS201-01 tablets inhibit parasite P. berghei and increase TGF-β expression on the placenta of infected mice.

References

  1. World Health Organization (WHO). The global burden of disease: 2004 update. WHO press. Genewa. Switzerland. 2008. http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/
  2. Rogerson SJ, Hviid L, Duffy PE, Leke RF, Taylor DW. Malaria in pregnancy: Pathogenesis and Immunity. Lancet Infect Dis. 2007; 7(2): 105-17. https://doi.org/10.1016/S1473-3099(07)70022-1
  3. World Health Organization (WHO). Guidelines for the Treatment of Malaria-third edition. WHO press. Genewa. Switzerland. 2015. http://www.who.int/malaria/publications/atoz/9789241549127/en/
  4. Nebl T, De Veer MJ, Schofield L. Stimulation of innate immune responses by malarial glycosylphosphatidylinositol via pattern recognition receptors. Parasitology. 2005; 130 (S1): S45-S62. https://doi.org/10.1017/S0031182005008152
  5. Lucchi NW, Koopman R, Peterson DS, Moore JM. Plasmodium falciparum-infected red blood cells selected for binding to cul¬tured syncytiotrophoblast bind to chondroitin sulfate A and in¬duce tyrosine phosphorylation in the syncytiotrophoblast. Pla¬centa. 2006; 27(4-5): 384-394. https://doi.org/10.1016/j.placenta.2005.04.009
  6. Omer FM, Kurtzhals JAL, Riley EM. Maintaining the Immunological Balance in Parasitic Infections: A Role for TGF-β?. Parasitology Today. 2000; 16 (1): 18-23. https://doi.org/10.1016/S0169-4758(99)01562-8
  7. Whitty CJ, Edmonds S, Mutabingwa TK. Malaria in Pregnancy. Journal of Obstetrics and Gynaecology. 2005; 112(9):1189-95. https://doi.org/10.1111/j.1471-0528.2005.00714.x
  8. World Health Organization (WHO). Guidelines for the treatment of malaria-second edition. WHO press. Genewa. Switzerland. 2010. http://apps.who.int/medicinedocs/en/d/Js19105en/.
  9. White TE, Bushdid PB, Ritter S, Laffan SB, Clark RL. Artesunate-induced depletion of embryonic erythroblasts precedes embryolethality and teratogenicity in vivo. Birth Defects Res B Dev Reprod Toxicol. 2006; 77(5):413-29. https://doi.org/10.1002/bdrb.20092
  10. Clark RL, Arima A, Makori N, Nakata Y, Bernard F, Gristwood W, et al. Artesunate: developmental toxicity and toxicokinetics in monkeys. Birth Defects Res B Dev Reprod Toxicol. 2008; 83(4):418-34. https://doi.org/10.1002/bdrb.20163
  11. Bero J, Quetin-Leclercq J. Natural products published in 2009 from plants traditionally used to treat malaria. Planta Med. 2011; 77(6):631-640. https://doi.org/10.1055/s-0030-1250405
  12. Nogueira CR, Lopes LMX. Antiplasmodial Natural Products. Molecules. 2011; 16: 2146-90. https://doi.org/10.3390/molecules16032146
  13. Yeung S, Damme W, Socheat D, White NJ, Mills A. Access to artemisinin combination therapy for malaria in remote areas of Cambodia. Malaria Journal. 2008; 7:96. https://doi.org/10.1186/1475-2875-7-96
  14. Okhuarobo A, Falodun JE, Erharuyi O, Imieje V, Falodun A, Langer P. Harnessing the medicinal properties of Andrographis paniculata for diseases and beyond: a review of its phytochemistry and pharmacology. Asian Pac J Trop Dis. 2014; 4(3): 213-222. https://doi.org/10.1016/S2222-1808(14)60509-0
  15. Widyawaruyanti A, Asrory M, Ekasari W, Setiawan D, Radjaram A, Tumewu L, et al. 2014. In vivo antimalarial activity of Andrographis paniculata tablets. Procedia Chemistry. 13: 101 – 104. https://doi.org/10.1016/j.proche.2014.12.012
  16. Widyawaruyanti A, Astrianto D, Ilmi H, Tumewu L, Setyawan D, Widiastuti E, et al. Antimalarial activity and survival time of Andrographis paniculata fraction (AS202-01) on Plasmodium berghei infected mice. Res J Pharm Biol Chem Sci. 2017; 8 (1S): 49-54. www.rjpbcs.com/pdf/2017_8(1S)/[8].pdf
  17. Bulmer JN, Rasheed FN, Francis N, Morrison L, Greenwoods BM. Placental malaria I. Pathological classification. Histopathology. 1993; 22(3): 211-218. https://doi.org/10.1111/j.1365-2559.1993.tb00110.x
  18. Novak M, Madej JA, Dziegeil P. Intensity of Cox2 expression in Cell of Soft Tissue Fibrosarcomas in Dog As Related to Grade of Tumor malignation. Bull Vet inst Pulawy. 2007; 51, 275-279. www.piwet.pulawy.pl/jvetres/images/.../20072275280.pdf
  19. Hviid L, Marinho CR, Staalsoe T, Penha-Goncalves C. Of mice and women: rodent models of placental malaria. Trends Parasitol. 2010; 26(8) 412–419. https://doi.org/10.1016/j.pt.2010.04.010
  20. Fried M, Muga RO, Misore AO, Duffy PE. Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes. J Immunol. 1998; 160(5): 2523-2530. http://www.jimmunol.org/content/160/5/2523
  21. Mahdiyanti SM. In vivo antimalarial of Andrographis paniculata Nees on Plasmodium berghei infected mice. Skripsi. Fakultas Farmasi Universitas Airlangga. Surabaya. Indonesia. 2004. (Article in Indonesian).
  22. Mishra K, Dash AP, Dey N. Andrographolide: A Novel antimalarial diterpene lactone compound from Andrographis paniculata and its interaction with curcumin and artesunate. Journal of Tropical Medicine. 2011. Article ID 579518. http://dx.doi.org/10.1155/2011/579518
  23. Wenisch C, Parschalk B, Burgmann H, Looareesuwan S, Graninger W. Decreased serum levels of TGF-beta in patients with acute Plasmodium falciparum malaria. J Clin Immunol. 1995; 15(2):69-73. http://www.jimmunol.org/content/160/5/2523.long
  24. Omer FM, Riley EM. Transforming growth factor β production is inversely correlated with severity of murine malaria infection. J Exp Med. 1998; 188(1):39–48. http://dx.doi.org/10.1084/jem.188.1.39
  25. Wahl SM, McCartney-Francis N, Mergenhagen SE. Inflammatory and immunomodulatory roles of TGF-β. Immunol. Today. 1989; 10(8):258–261. http://dx.doi.org/10.1016/0167-5699(89)90136-9

How to Cite

Widyawaruyanti, A., Rachmat, J., Viandika, N., Ilmi, H., Tumewu, L., & Prasetyo, B. (2018). Effect of Andrographis paniculata tablet (AS201-01) on Transforming Growth Factor Beta (TGF-β) expression and parasite inhibition in mice placenta infected with Plasmodium berghei. Bali Medical Journal, 7(1), 210–214. https://doi.org/10.15562/bmj.v7i1.785

HTML
0

Total
0

Share